Titre : Hémoglobine C

Hémoglobine C : Questions médicales fréquentes

{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Hémoglobine C : Questions médicales les plus fréquentes", "headline": "Hémoglobine C : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Hémoglobine C : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-16", "dateModified": "2025-04-11", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Hémoglobine C" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Hémoglobines anormales", "url": "https://questionsmedicales.fr/mesh/D006455", "about": { "@type": "MedicalCondition", "name": "Hémoglobines anormales", "code": { "@type": "MedicalCode", "code": "D006455", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.422.316.762.426" } } }, "about": { "@type": "MedicalCondition", "name": "Hémoglobine C", "alternateName": "Hemoglobin C", "code": { "@type": "MedicalCode", "code": "D006444", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Mei Zhang", "url": "https://questionsmedicales.fr/author/Mei%20Zhang", "affiliation": { "@type": "Organization", "name": "Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu 610041, China." } }, { "@type": "Person", "name": "Benjamin Fröhlich", "url": "https://questionsmedicales.fr/author/Benjamin%20Fr%C3%B6hlich", "affiliation": { "@type": "Organization", "name": "1Physical Chemistry of Biosystems, Heidelberg University, Im Neuenheimer Feld 253, 69120 Heidelberg, Germany." } }, { "@type": "Person", "name": "Christine Lansche", "url": "https://questionsmedicales.fr/author/Christine%20Lansche", "affiliation": { "@type": "Organization", "name": "3Department of Infectious Diseases, Parasitology, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 324, 69120 Heidelberg, Germany." } }, { "@type": "Person", "name": "Michael Lanzer", "url": "https://questionsmedicales.fr/author/Michael%20Lanzer", "affiliation": { "@type": "Organization", "name": "3Department of Infectious Diseases, Parasitology, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 324, 69120 Heidelberg, Germany." } }, { "@type": "Person", "name": "Motomu Tanaka", "url": "https://questionsmedicales.fr/author/Motomu%20Tanaka", "affiliation": { "@type": "Organization", "name": "1Physical Chemistry of Biosystems, Heidelberg University, Im Neuenheimer Feld 253, 69120 Heidelberg, Germany." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Hemoglobin-to-RDW ratio, hemoglobin-to-monocyte ratio, and hemoglobin-to-leukocyte ratio are predictive of 14-day readmission after primary total knee arthroplasty.", "datePublished": "2024-10-26", "url": "https://questionsmedicales.fr/article/39456066", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13018-024-05116-w" } }, { "@type": "ScholarlyArticle", "name": "Analysis of annual distributions of hemoglobin A", "datePublished": "2023-09-23", "url": "https://questionsmedicales.fr/article/37748747", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.cca.2023.117564" } }, { "@type": "ScholarlyArticle", "name": "MicroRNA29B induces fetal hemoglobin", "datePublished": "2022-11-25", "url": "https://questionsmedicales.fr/article/36507536", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fmed.2022.1043686" } }, { "@type": "ScholarlyArticle", "name": "Nanomaterials for Fluorescent Detection of Hemoglobin.", "datePublished": "2024-01-16", "url": "https://questionsmedicales.fr/article/38227424", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/10408347.2023.2301660" } }, { "@type": "ScholarlyArticle", "name": "Interference of hemoglobin variants in HbA", "datePublished": "2022-12-05", "url": "https://questionsmedicales.fr/article/36476843", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.cca.2022.11.031" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Hémoprotéines", "item": "https://questionsmedicales.fr/mesh/D006420" }, { "@type": "ListItem", "position": 5, "name": "Globines", "item": "https://questionsmedicales.fr/mesh/D005914" }, { "@type": "ListItem", "position": 6, "name": "Hémoglobines", "item": "https://questionsmedicales.fr/mesh/D006454" }, { "@type": "ListItem", "position": 7, "name": "Hémoglobines anormales", "item": "https://questionsmedicales.fr/mesh/D006455" }, { "@type": "ListItem", "position": 8, "name": "Hémoglobine C", "item": "https://questionsmedicales.fr/mesh/D006444" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Hémoglobine C - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Hémoglobine C", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-04", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Hémoglobine C", "description": "Comment diagnostiquer l'hémoglobine C ?\nQuels tests sont utilisés pour l'hémoglobine C ?\nL'hémoglobine C est-elle héréditaire ?\nQuels symptômes indiquent un test pour l'hémoglobine C ?\nPeut-on détecter l'hémoglobine C à la naissance ?", "url": "https://questionsmedicales.fr/mesh/D006444?page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Hémoglobine C", "description": "Quels sont les symptômes de l'hémoglobine C ?\nL'hémoglobine C cause-t-elle de l'anémie ?\nY a-t-il des complications liées à l'hémoglobine C ?\nLes symptômes varient-ils selon l'âge ?\nL'hémoglobine C provoque-t-elle des douleurs ?", "url": "https://questionsmedicales.fr/mesh/D006444?page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Hémoglobine C", "description": "Peut-on prévenir l'hémoglobine C ?\nLe dépistage est-il recommandé ?\nComment éviter les complications ?\nLes conseils génétiques sont-ils utiles ?\nY a-t-il des vaccinations recommandées ?", "url": "https://questionsmedicales.fr/mesh/D006444?page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Hémoglobine C", "description": "Comment traite-t-on l'hémoglobine C ?\nLes transfusions sont-elles nécessaires ?\nY a-t-il des médicaments spécifiques pour l'hémoglobine C ?\nLa thérapie génique est-elle une option ?\nComment gérer les crises douloureuses ?", "url": "https://questionsmedicales.fr/mesh/D006444?page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Hémoglobine C", "description": "Quelles sont les complications possibles ?\nL'hémoglobine C augmente-t-elle le risque d'infections ?\nY a-t-il un risque de crise vaso-occlusive ?\nLes problèmes hépatiques sont-ils fréquents ?\nComment surveiller les complications ?", "url": "https://questionsmedicales.fr/mesh/D006444?page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Hémoglobine C", "description": "Quels sont les facteurs de risque de l'hémoglobine C ?\nL'origine ethnique influence-t-elle le risque ?\nLes antécédents familiaux sont-ils importants ?\nLe mode de vie affecte-t-il le risque ?\nLes femmes enceintes doivent-elles être testées ?", "url": "https://questionsmedicales.fr/mesh/D006444?page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer l'hémoglobine C ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un test sanguin spécifique, comme l'électrophorèse de l'hémoglobine, permet de diagnostiquer." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour l'hémoglobine C ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent l'électrophorèse et le dosage de l'hémoglobine C dans le sang." } }, { "@type": "Question", "name": "L'hémoglobine C est-elle héréditaire ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'hémoglobine C est une condition génétique transmise par les parents." } }, { "@type": "Question", "name": "Quels symptômes indiquent un test pour l'hémoglobine C ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme l'anémie ou des douleurs abdominales peuvent justifier un test." } }, { "@type": "Question", "name": "Peut-on détecter l'hémoglobine C à la naissance ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le dépistage néonatal peut inclure des tests pour l'hémoglobine C." } }, { "@type": "Question", "name": "Quels sont les symptômes de l'hémoglobine C ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fatigue, jaunisse, et douleurs osseuses ou abdominales." } }, { "@type": "Question", "name": "L'hémoglobine C cause-t-elle de l'anémie ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'hémoglobine C peut entraîner une anémie due à la destruction des globules rouges." } }, { "@type": "Question", "name": "Y a-t-il des complications liées à l'hémoglobine C ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des complications peuvent inclure des crises douloureuses et des infections fréquentes." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'âge ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent être plus prononcés chez les enfants et les jeunes adultes." } }, { "@type": "Question", "name": "L'hémoglobine C provoque-t-elle des douleurs ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des douleurs peuvent survenir en raison de la vaso-occlusion des vaisseaux sanguins." } }, { "@type": "Question", "name": "Peut-on prévenir l'hémoglobine C ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Étant génétique, l'hémoglobine C ne peut pas être prévenue, mais des conseils génétiques aident." } }, { "@type": "Question", "name": "Le dépistage est-il recommandé ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le dépistage est recommandé pour les personnes à risque, notamment les porteurs." } }, { "@type": "Question", "name": "Comment éviter les complications ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Une bonne hydratation et des soins médicaux réguliers aident à éviter les complications." } }, { "@type": "Question", "name": "Les conseils génétiques sont-ils utiles ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les conseils génétiques aident les familles à comprendre les risques de transmission." } }, { "@type": "Question", "name": "Y a-t-il des vaccinations recommandées ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des vaccinations contre certaines infections sont recommandées pour les patients." } }, { "@type": "Question", "name": "Comment traite-t-on l'hémoglobine C ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement peut inclure des transfusions sanguines et des médicaments pour l'anémie." } }, { "@type": "Question", "name": "Les transfusions sont-elles nécessaires ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des transfusions peuvent être nécessaires en cas d'anémie sévère ou de complications." } }, { "@type": "Question", "name": "Y a-t-il des médicaments spécifiques pour l'hémoglobine C ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments comme l'hydroxyurée peuvent être prescrits pour réduire les crises." } }, { "@type": "Question", "name": "La thérapie génique est-elle une option ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie génique est en recherche, mais pas encore une option standard pour l'hémoglobine C." } }, { "@type": "Question", "name": "Comment gérer les crises douloureuses ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des analgésiques et une hydratation adéquate aident à gérer les crises douloureuses." } }, { "@type": "Question", "name": "Quelles sont les complications possibles ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des infections, des crises douloureuses et des problèmes hépatiques." } }, { "@type": "Question", "name": "L'hémoglobine C augmente-t-elle le risque d'infections ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les patients ont un risque accru d'infections en raison de l'anémie et de la splénomégalie." } }, { "@type": "Question", "name": "Y a-t-il un risque de crise vaso-occlusive ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les crises vaso-occlusives peuvent survenir, provoquant des douleurs intenses." } }, { "@type": "Question", "name": "Les problèmes hépatiques sont-ils fréquents ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Des problèmes hépatiques peuvent survenir, surtout en cas de transfusions fréquentes." } }, { "@type": "Question", "name": "Comment surveiller les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des examens réguliers et des bilans sanguins aident à surveiller les complications." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque de l'hémoglobine C ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux et l'origine ethnique, notamment africaine." } }, { "@type": "Question", "name": "L'origine ethnique influence-t-elle le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes d'origine africaine ou méditerranéenne sont plus à risque." } }, { "@type": "Question", "name": "Les antécédents familiaux sont-ils importants ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, avoir des membres de la famille atteints augmente le risque de développer l'hémoglobine C." } }, { "@type": "Question", "name": "Le mode de vie affecte-t-il le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain peut réduire les complications, mais ne prévient pas la condition." } }, { "@type": "Question", "name": "Les femmes enceintes doivent-elles être testées ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le dépistage est recommandé pour les femmes enceintes à risque d'hémoglobine C." } } ] } ] }

Sources (10000 au total)

Hemoglobin-to-RDW ratio, hemoglobin-to-monocyte ratio, and hemoglobin-to-leukocyte ratio are predictive of 14-day readmission after primary total knee arthroplasty.

Total knee arthroplasty (TKA) is an effective treatment for knee osteoarthritis; however, early readmissions due to complications are common. This study assessed the ability of the hemoglobin-to-red c... Data from the Chang Gung Medical Research Database (CGRD) from 2014 to 2022 were retrospectively analyzed. Patients ≥ 20 years old who underwent primary TKA were eligible for inclusion. Patients with ... Data from 1,137 patients were analyzed. Multivariable analysis revealed that a higher HMR was significantly associated with lower 14-day readmission risk (adjusted OR [aOR] = 0.72, 95% confidence inte... High HMR and the HRR-HMR-HLR score are independently associated with a lower 14-day readmission risk after TKA. Implementing these indices into clinical practice may enhance postoperative management....

Analysis of annual distributions of hemoglobin A

The monitoring of yearly distributions of HbA... Measurements/year of HbA... According to the overlapping areas analysis the distributions/year of the data provided by 4 centers able to perform at least 1000 measurements/year were similar in 2 consecutive years. Moreover, the ... Despite the limitations of this study the yearly distribution of the HbA...

A clinical update of compound heterozygosity for hemoglobin Hekinan II [a27(B8)Glu-Asp; HBA1: c.84G>T] variant in China.

Hemoglobin (Hb) Hekinan II (A27; Glu-Asp) is an α-chain variant, and its interaction with the common Southeast Asian (--SEA/) α-thalassemia (α-thal) deletion is rarely reported. This study provides a ... A total of 11 simple heterozygotes and 20 composite heterozygotes for Hb Hekinan II and (--SEA/) α-thal were included based on molecular diagnosis.... Hb Hekinan II exhibited a significant increase in hemoglobin, mean corpuscular volume, and mean corpuscular hemoglobin content, but a decrease in red blood cell level compared with α+ thalassemia dele... Hb Hekinan II is a benign Hb variant. The heterozygotes exhibit clinically asymptomatic coinheritance with (--SEA/) α-thal having comparable hematological phenotype to simple (--SEA/) α-thal. The comb...

Hemoglobin homeostasis in abdominal aortic aneurysm: diagnostic and prognostic potential of hemoglobin/heme and scavenger molecules.

There is increasing evidence implicating hemoglobin/heme and their scavengers in oxidative stress-mediated pathologies, but information is limited in abdominal aortic aneurysm (AAA).... In this case-control study, we assessed heme/heme-related markers in 142 men with AAA and 279 men with a normal aortic diameter consecutively recruited from an ultrasound screening program in Sweden. ... This study reports the distinct disruption of heme and related markers in both the development and progression of AAA, underscoring their potential in aiding risk stratification and therapeutic strate...

Agreement between Noninvasive Hemoglobin and Laboratory Hemoglobin Measurements in Neonates: A Systematic Review and Meta-Analysis.

The noninvasive hemoglobin (NHb) devices are recently evaluated as an alternative to laboratory hemoglobin (LHb) in neonates. This systematic review explores the diagnostic accuracy of NHb devices for... Literature related to the comparison of NHb device with LHb in neonates was searched from Medline, PubMed Central, PubMed, Web of Science, Google Scholar, and Scopus databases after PROSPERO registrat... A total of 1,477 paired NHb-LHb observations were analyzed from 1,047 neonates in 10 studies. Massimo radical-pulse co-oximetry (8 studies) and Mediscan-2000 (2 studies) were used for NHb estimation. ... Hemoglobin measurement by NHb is excellently correlated with LHb measurement with a minimal average difference. It may be used as a screening tool for hemoglobin measurement in neonates to avoid frequ...